Theravance Biopharma Inc. (TBPH)
8.64
0.11 (1.29%)
At close: Jan 15, 2025, 3:59 PM
8.61
-0.35%
After-hours Jan 15, 2025, 04:00 PM EST
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov 12, 2024
(Q3) AMC Q3 2024 | 8.94 | 9.08 | 8.91 | 9.47 | 10.26 | 9.33 | 9.68 | 9.57 | 9.52 | 9.49 | 9.97 | 8.71 | ||
IV: 0.8 RSI: 59 TBPH % | 2.17% | 1.57% | 1.57% | 6.29%
| 15.15%
| 4.71%
| 8.64%
| -1.14% | -0.52% | -0.32% | 0.50% | 5.32% | ||
Aug 5, 2024
(Q2) AMC Q2 2024 | 10.03 | 9.64 | 9.59 | 8.65 | 9.18 | 7.69 | 7.83 | 7.83 | 7.68 | 7.66 | 8.28 | 10.06 | ||
IV: 0.66 RSI: 49 TBPH % | -0.79% | -3.89% | -3.89% | -9.80%
| -4.28%
| -19.81%
| -18.35%
| 0.00% | -1.92% | -0.26% | 0.49% | -0.49% | ||
May 13, 2024
(Q1) AMC Q1 2024 | 9.47 | 9.38 | 9.58 | 9.74 | 9.99 | 9.32 | 9.39 | 9.85 | 9.60 | 9.29 | 9.12 | 9.54 | ||
IV: 0.49 RSI: 56 TBPH % | -0.21% | -0.95% | -0.95% | 1.67%
| 4.28%
| -2.71%
| -1.98%
| 4.90% | -2.54% | -3.23% | 0.22% | -0.63% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.